References
- Akbuga J. Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization. Int J Pharm 1989; 53: 99–105
- Barakat NS, Ahmad AAE. Diclofenac sodium loaded-cellulose acetate butyrate: Effect of processing variables on microparticles properties, drug release kinetics and ulcerogenic activity. J Microencapsulation 2008; 25: 31–45
- Chowdary KPR, Balatipura G. Design and in vitro evaluation of mucoadhesive controlled tablet of glipizide. Ind J Pharm Sci 2003; 65: 591–594
- Chowdary KPR, Rao YS, 2003. Design and in vitro evaluation of mucoadhesive microcapsules of glipizde for oral controlled release: A technical note. AAPS PharmSciTech 4:E39
- Davis SS, Illum L. Polymeric microspheres as drug carriers. Biomaterials 1988; 9: 111–115
- Esposito E, Sebben S, Cortesi R, Menegatti E, Nastruzzi C. Preparation and characterization of cationic microspheres for gene delivery. Int J Pharm 1999; 189: 29–41
- Foster RH, Plosker GL. Glipizide: a review of the pharmacoeconomic implications of the extended release formulation in type 2 diabetes mellitus. Pharmacoeconomics 2000; 18: 289–306
- Gadsby R. Epidemiology of diabetes. Adv Drug Del Rev 2002; 54: 1165–1172
- Gutcho MH, editor. Microcapsules and microencapsulation techniques. Noyes Data Corporation., New Jersey 1976; 236
- Haznedar S, Dortunc B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm 2004; 269: 131–140
- Jain D, Panda AK, Majumdar DK. Eudragit S 100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech 2005; 6: E100–E107
- Jayvadan KP, Rakesh PP, Avani FA, Madhabhai M. AAPS PharmSciTech 6:Article 10. Formulation and evaluation of mucoadhesive glipizide microspheres 2005, Available online at http://www.aapspharmscitech.org, [accessed 05.04.2006]
- Kahn CR, Shechter Y. Oral hypoglycemic agents and the pharmacology of the endocrine pancreas. Goodman and Gilman's The pharmacological basis of therapeutics, 8th ed, WR Theodore, SN Alan, P Taylor, AG Gilman. McGraw-Hill, New York 1991; 1484
- Katare YK, Muthukumaran T, Panda AK. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int J Pharm 2005; 301: 149–160
- Katare YK, Panda AK. Influence of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymeric particles. Eur J Pharm Sci 2006; 28: 179–188
- Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, Itoh K. Preparation of controlled release microspheres of ibuprofen with acrylic polymers by a novel quassi-emulsion solvent diffusion method. J Pharm Sci 1989; 78: 68–72
- Kondo A, editor. 1979. Microcapsule processing and technology. New York: Marcel Decker inc, p 18.
- Leaf E, King JO. Patient outcomes after formulary conversion from immediate-release to extended release glipizide tablets. Am J Health-Syst Pharm 1999; 56: 454–456
- Leung SS, Robinson JR. Parental products: In:. Robinson JR, Lee VHL, editors. Controlled drug delivery, fundamentals and applications, 2nd ed. Marcel Decker, Inc, New York 1987; 448
- Naha PC, Kanchan V, Manna PK, Panda AK. Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles. J Microencapsulation 2008; 25: 1–9
- Raghuvanshi RS, Katare YK, Lalwani K, Ali MM, Singh OM, Panda AK. Improved immuno response from biodegradable polymer particles entrapping tetatnus toxoid by use of different immunization protocol and adjuvants. Int J Pharm 2002; 245: 109–121
- Raghuvanshi RS, Singh OM, Panda AK. Formulation and characterisation of immunoreactive tetanus toxoid biodegradable polymer particles. Drug Deliv 2001; 8: 99–106
- Ritschel WA. Biopharmaceutics and pharmacokinetic aspects in the design of controlled release per oral drug delivery systems. Drug Dev Ind Pharm 1989; 15: 1073–1103
- Sweetman S, editor. 2005. Martindale: The complete drug reference. Electronic version. London: Pharmaceutical Press.
- The United States Pharmacopoeia, XXVI. 2003. Rockville, MD: The United States Pharmacopoeial convention, Inc. p 2528.
- Thombre AG, Denoto AR, Gibbes DC. Delivery of glipizide from asymmetric membrane capsules using encapusulated excipients. J Contr Rel 1999; 60: 333–341
- Vyas SP, Khar RK, editors. Targeted and controlled drug delivery, novel carrier systems, 1st ed. CBS Publishers., New Delhi 2002; 418